| Year |
Citation |
Score |
| 2013 |
McCoy A, Besch-Williford CL, Franklin CL, Weinstein EJ, Cui X. Creation and preliminary characterization of a Tp53 knockout rat. Disease Models & Mechanisms. 6: 269-78. PMID 22917926 DOI: 10.1242/Dmm.009704 |
0.364 |
|
| 2010 |
Duan Z, Ji D, Weinstein EJ, Liu X, Susa M, Choy E, Yang C, Mankin H, Hornicek FJ. Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma. Cancer Letters. 293: 220-9. PMID 20144850 DOI: 10.1016/j.canlet.2010.01.014 |
0.401 |
|
| 2010 |
Yang C, Ji D, Weinstein EJ, Choy E, Hornicek FJ, Wood KB, Liu X, Mankin H, Duan Z. The kinase Mirk is a potential therapeutic target in osteosarcoma. Carcinogenesis. 31: 552-8. PMID 20042639 DOI: 10.1093/carcin/bgp330 |
0.305 |
|
| 2007 |
Ji D, Deeds SL, Weinstein EJ. A screen of shRNAs targeting tumor suppressor genes to identify factors involved in A549 paclitaxel sensitivity. Oncology Reports. 18: 1499-505. PMID 17982636 |
0.344 |
|
| 2006 |
Weinstein EJ, Head R, Griggs DW, Sun D, Evans RJ, Swearingen ML, Westlin MM, Mazzarella R. VCC-1, a novel chemokine, promotes tumor growth. Biochemical and Biophysical Research Communications. 350: 74-81. PMID 16989774 DOI: 10.1016/j.bbrc.2006.08.194 |
0.447 |
|
| 2005 |
Hardwick JS, Yang Y, Zhang C, Shi B, McFall R, Koury EJ, Hill SL, Dai H, Wasserman R, Phillips RL, Weinstein EJ, Kohl NE, Severino ME, Lamb JR, Sepp-Lorenzino L. Identification of biomarkers for tumor endothelial cell proliferation through gene expression profiling. Molecular Cancer Therapeutics. 4: 413-25. PMID 15767550 DOI: 10.1158/1535-7163.MCT-04-0209 |
0.376 |
|
| 2003 |
Swearingen ML, Sun D, Bourner M, Weinstein EJ. Detection of differentially expressed HES-6 gene in metastatic colon carcinoma by combination of suppression subtractive hybridization and cDNA library array. Cancer Letters. 198: 229-39. PMID 12957362 DOI: 10.1016/S0304-3835(03)00313-6 |
0.394 |
|
| 2000 |
Weinstein EJ, Leder P. The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis. Cancer Research. 60: 3856-61. PMID 10919660 |
0.545 |
|
| 2000 |
Weinstein EJ, Kitsberg DI, Leder P. A mouse model for breast cancer induced by amplification and overexpression of the neu promoter and transgene. Molecular Medicine (Cambridge, Mass.). 6: 4-16. PMID 10803404 DOI: 10.1007/Bf03401930 |
0.445 |
|
| 1998 |
Weinstein EJ, Grimm S, Leder P. The oncogene heregulin induces apoptosis in breast epithelial cells and tumors. Oncogene. 17: 2107-13. PMID 9798682 DOI: 10.1038/Sj.Onc.1202428 |
0.537 |
|
| 1998 |
Grimm S, Weinstein EJ, Krane IM, Leder P. Neu differentiation factor (NDF), a dominant oncogene, causes apoptosis in vitro and in vivo. The Journal of Experimental Medicine. 188: 1535-9. PMID 9782131 DOI: 10.1084/Jem.188.8.1535 |
0.512 |
|
| 1998 |
Tulchin N, Ornstein L, Bleiweiss IJ, Mendlowitz M, Weinstein E, Dikman SH. Nucleolar localization of BRCA1 protein in human breast cancer International Journal of Oncology. 13: 513-518. PMID 9683786 |
0.304 |
|
| Show low-probability matches. |